secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-01-07T23:59:59+00:00
Accession:  0001213900-25-001663
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics reports cash balance of ~$5.5M as of Jan 7, 2025 after warrant exercises and equity line sales
--------------------------------------------------------------------------------

- Cash balance of approximately $5.463 million as of January 7, 2025.
- Funds raised through warrant exercises for Series A Preferred Stock and sales under committed equity financing facility.
- Filing updates prior 8-K on Dec 31, 2024; no other material changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025001663/0001213900-25-001663-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025001663/ea0227074-8k_cerotherap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-001663

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer